SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Corbalan R.)
 

Search: WFRF:(Corbalan R.) > Geographic Differen...

Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial)

Metra, M. (author)
Mentz, R. J. (author)
Hernandez, A. F. (author)
show more...
Heizer, G. M. (author)
Armstrong, P. W. (author)
Clausell, N. (author)
Corbalan, R. (author)
Costanzo, M. R. (author)
Dickstein, K. (author)
Dunlap, M. E. (author)
Ezekowitz, J. A. (author)
Howlett, J. G. (author)
Komajda, M. (author)
Krum, H. (author)
Lombardi, C. (author)
Fonarow, G. C. (author)
McMurray, J. J. V. (author)
Nieminen, M. S. (author)
Swedberg, Karl, 1944 (author)
Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine
Voors, A. A. (author)
Starling, R. C. (author)
Teerlink, J. R. (author)
O'Connor, C. M. (author)
show less...
 (creator_code:org_t)
Elsevier BV, 2016
2016
English.
In: American Journal of Cardiology. - : Elsevier BV. - 0002-9149. ; 117:11, s. 1771-1778
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • A growing number of countries and geographical regions are involved in major clinical trials. Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure is the largest trial in acutely decompensated heart failure (HF) with patients from 5 geographical regions: North America (NA), Latin America (LA), Western Europe (WE), Central Europe (CE), and Asia-Pacific (AP). Data from the 5 geographical, areas were compared including baseline characteristics, medications, 30-day outcomes (mortality and mortality or HF hospitalization), and 180-day mortality. Of the 7,141 study patients, 3,243 (45.4%) were from NA (average of 15.2 patients/site), 1,762 (24.7%) from AP (28.4 patients/site), 967 (13.5%) from CE (20.2 patients/site), 665 (9.3%) from LA (17.1 patients/site), and 504 (7.1%) from WE (14.4 patients/site). There were marked differences in co-morbidities, clinical profile, medication use, length of stay, 30-day event rates, and 180-day mortality by region. Compared with NA, the adjusted risk for death or HF hospitalization at 30 days was significantly lower in CE (odds ratio [OR] 0.46, 95% CI 0.33 to 0.64), WE (OR 0.52 95% CI 0.35 to 0.75), and AP (OR 0.62 95% CI 0.48 to 0:79) and numerically lower in LA (OR 0.77, 95% CI 0.57 to 1.04) with similar results for 180-day mortality. In conclusion, in patients with acutely decompensated HF, major differences in baseline characteristics, treatments, length of the hospital stay, and 30-day HF rehospitalization rates, and 180-day mortality were found in patients enrolled from different, geographical areas. (C) 2016 Elsevier Inc. All rights reserved.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)

Keyword

acute myocardial-infarction
international differences
readmission
rates
outcomes
management
nesiritide
globalization
clopidogrel
ticagrelor
countries
Cardiovascular System & Cardiology

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view